Previous findings suggest that the level of NPY is likely to increase in peripheral neurons and adrenergic receptors due to obesity and metabolic diseases by modulating the level of endocannabinoids and CB1 receptors. Here, NPY is linked to obesity due to melanocortin 4 receptor deficiency.